Axon Enterprise, INC Form 4 insider transactions

NASDAQ
Brittany Bagley, COO & CFO of Axon Enterprise, sold 3,400 shares of common stock on May 13, 2025.
NASDAQ
Director Caitlin Elizabeth Kalinowski of Axon Enterprise, Inc. sold 800 shares of common stock on May 13, 2025, at a price of $713.25 per share.
NASDAQ
Director Matthew McBrady of Axon Enterprise, Inc. sold 400 shares of common stock at a weighted average price of $718.4043 on May 14, 2025.
NASDAQ
Axon Enterprise's President, Joshua Isner, executed multiple sales of common stock on May 12, 2025, at prices ranging from $667.21 to $701.67.
NASDAQ
Director Julie A. Cullivan sold 657 shares of Axon Enterprise, Inc. common stock at $700 per share on May 12, 2025, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Director Jeri Williams sold 657 shares of Axon Enterprise, Inc. common stock on May 12, 2025, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise's CEO, Patrick W. Smith, sold shares of common stock on April 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Brittany Bagley, COO & CFO of Axon Enterprise, disposed of 1,250 shares of common stock on March 26, 2025, to cover tax liabilities from vesting restricted stock units.
NASDAQ
Brittany Bagley, COO & CFO of Axon Enterprise, acquired 61,120 shares of common stock on March 24, 2025, related to performance-based restricted stock units.
NASDAQ
Joshua Isner, President of Axon Enterprise, reports acquiring and disposing of common stock related to performance-based restricted stock units.
NASDAQ
Axon Enterprise's CPO & CTO, Jeffrey Kunins, reports acquiring 41,236 shares of common stock and discloses details regarding performance-based restricted stock units.
NASDAQ
Axon Enterprise's CEO, Patrick W. Smith, acquired 194,030 shares of common stock on March 24, 2025, through the vesting of performance-based restricted stock units.
NASDAQ
Director Jeri Williams sold 307 shares of Axon Enterprise, Inc. common stock at a price of $552.72 per share on March 17, 2025, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise director Caitlin Elizabeth Kalinowski sold 450 shares of common stock on January 2, 2025, for a total of $271,628, according to a Form 4 filing with the SEC.
NASDAQ
Axon Enterprise's COO, Brittany Bagley, sold 1,272 shares of common stock to cover tax liabilities from vesting restricted stock units.
NASDAQ
Jeffrey Kunins, CPO & CTO of Axon Enterprise, reports the sale of common stock on December 23, 2024, to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise's President, Joshua Isner, sold a total of 1,291 shares of common stock in multiple transactions, including shares withheld for tax obligations, as part of a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise's Chief Product and Technology Officer, Jeffrey C. Kunins, sold a portion of his shares to cover tax obligations and under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise CEO Patrick W. Smith gifted a total of 45,108 common shares to family trusts and a donor advised fund on December 13, 2024.
NASDAQ
Axon Enterprise director Michael Garnreiter sold 1,000 shares of common stock on December 16, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise, Inc. at an average price of $682.0596 on December 4, 2024.
NASDAQ
Axon Enterprise's Chief Product and Technology Officer, Jeffrey C. Kunins, sold a portion of his shares to cover tax obligations and pursuant to a pre-arranged trading plan.
NASDAQ
Axon Enterprise's President, Joshua Isner, sold a total of 3,780 shares of common stock between December 2nd and December 4th, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise's COO & CFO, Brittany Bagley, sold 3,500 shares of common stock on November 22, 2024.
NASDAQ
Axon Enterprise's President, Joshua Isner, sold a total of 9,600 shares of common stock in multiple transactions on November 21, 2024.
NASDAQ
Matthew R. McBrady, a director at Axon Enterprise, sold a total of 1,000 shares of common stock in multiple transactions on November 20, 2024.
NASDAQ
Axon Enterprise's COO & CFO, Brittany Bagley, sold a total of 6,325 shares of common stock on November 15, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Michael Garnreiter, a director at Axon Enterprise, sold 1,000 shares of common stock at $599.53 per share under a pre-arranged 10b5-1 trading plan.
NASDAQ
Axon Enterprise's Chief Product and Technology Officer, Jeffrey C. Kunins, sold a total of 38,668 shares of common stock across multiple transactions on November 12th and 13th, 2024.
NASDAQ
Axon Enterprise's President, Joshua Isner, sold a significant number of shares and made a charitable donation of stock, according to a recent SEC filing.